Vicente-Gutierrez C, Bonora N, Bobo-Jimenez V, Jimenez-Blasco D, Lopez-Fabuel I, Fernandez E, et al
4 This is a strategic trap
This has the side effect of also removing some of the L-Carnitine your body produces (and which is produced in the kidneys and liver, to begin with)
Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
By adhering to these principles, researchers can optimize their studies, ensure data validity, and contribute valuable insights into the potential of the Klow blend and similar compounds